Differential diagnosis of drug-induced toxicity and infectious disorder in haematological malignancies

U. Costabel (Essen, Germany)

Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity
Session: PG7 Drug-induced pulmonary toxicity
Session type: Postgraduate Course
Number: 62

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Costabel (Essen, Germany). Differential diagnosis of drug-induced toxicity and infectious disorder in haematological malignancies. Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
BAL as a diagnostic tool in severe pneumonia in patients with hematological malignancies
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007


Respiratory manifestations in hospitalized patients with hematological malignancies
Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Year: 2015

Endoscopic diagnostics of bronchopulmonary changes in patients with malignant hematological diseases
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008

Risk factors for impaired pulmonary function in adult survivors of childhood hematological and non-hematological malignancies
Source: Virtual Congress 2020 – Management of chronic lung conditions
Year: 2020

Pulmonary manifestations of haematological diseases: from lymphoma to sickle cell crisis
Source: International Congress 2018 – Respiratory medicine meets hematology
Year: 2018


Manifestations of malignancies during the course of sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Diagnostic yield and safety of flexible bronchoscopy for the diagnosis of pulmonary infections in patients with and without haematological malignancies
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019

Pulmonary complications in patients with hematologic diseases
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012

Post-transplant lymphoproliferative disease and other malignancies
Source: Eur Respir Mon; 2009: 45: 226–237
Year: 2009

Early symptoms in lung cancer: the paraneoplasic syndromes
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

Is bronchoscopy essential for pulmonary infections in patients with haematological malignancies?
Source: Breathe, 16 (4) 200268; 10.1183/20734735.0268-2020
Year: 2020



Lymphoproliferative disease and other malignancies
Source: ERS Course 2016
Year: 2016



Differential diagnosis of granulomatous lung disease: clues and pitfalls
Source: Eur Respir Rev, 26 (145) 170012; 10.1183/16000617.0012-2017
Year: 2017



Could LDH monitoring after lung transplantation be used as screening tool for post-transplant lymphoproliferative disorder (PTLD)?
Source: International Congress 2017 – Lung transplant outcomes
Year: 2017

Acute and chronic cough syndromes differential diagnosis: infections or not?
Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection
Year: 2007



Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


The pulmonary disorders associated with autoimmune pancreatitis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Pulmonary manifestations of endocrine and metabolic disorders
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=234
Year: 2005